172 related articles for article (PubMed ID: 23470153)
21. A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4).
Choi PY; Roncolato F; Badoux X; Ramanathan S; Ho SJ; Chong BH
Blood; 2015 Jul; 126(4):500-3. PubMed ID: 25972158
[TBL] [Abstract][Full Text] [Related]
22. High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis.
Mithoowani S; Gregory-Miller K; Goy J; Miller MC; Wang G; Noroozi N; Kelton JG; Arnold DM
Lancet Haematol; 2016 Oct; 3(10):e489-e496. PubMed ID: 27658982
[TBL] [Abstract][Full Text] [Related]
23. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
24. Long-term effect of high-dose dexamethasone with or without low-dose dexamethasone maintenance in untreated immune thrombocytopenia.
Din B; Wang X; Shi Y; Li Y
Acta Haematol; 2015; 133(1):124-8. PubMed ID: 25247485
[TBL] [Abstract][Full Text] [Related]
25. Low-dose rituximab therapy for refractory thrombocytopenia in patients with systemic lupus erythematosus--a prospective pilot study.
Chen H; Zheng W; Su J; Xu D; Wang Q; Leng X; Zhang W; Li M; Tang F; Zhang X; Zeng X; Zhao Y; Zhang F
Rheumatology (Oxford); 2011 Sep; 50(9):1640-4. PubMed ID: 21571767
[TBL] [Abstract][Full Text] [Related]
26. Multiple cycles of rituximab therapy in chronic refractory immune thrombocytopenia: a case report with a 10-year follow-up.
Routy B; Boulassel MR; Spurll GM; Warner MN; Routy JP
Am J Ther; 2013; 20(2):219-22. PubMed ID: 23466621
[TBL] [Abstract][Full Text] [Related]
27. Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia.
Zaja F; Baccarani M; Mazza P; Bocchia M; Gugliotta L; Zaccaria A; Vianelli N; Defina M; Tieghi A; Amadori S; Campagna S; Ferrara F; Angelucci E; Usala E; Cantoni S; Visani G; Fornaro A; Rizzi R; De Stefano V; Casulli F; Battista ML; Isola M; Soldano F; Gamba E; Fanin R
Blood; 2010 Apr; 115(14):2755-62. PubMed ID: 20130241
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy and safety of two different low-dose rituximab regimens for Chinese adult patients with immune thrombocytopenia].
Sui T; Zhang L; Zhou ZP; Xue F; Ge J; Yang RC
Zhonghua Xue Ye Xue Za Zhi; 2011 Sep; 32(9):583-6. PubMed ID: 22338149
[TBL] [Abstract][Full Text] [Related]
29. A single cycle of rituximab for the treatment of severe pemphigus.
Joly P; Mouquet H; Roujeau JC; D'Incan M; Gilbert D; Jacquot S; Gougeon ML; Bedane C; Muller R; Dreno B; Doutre MS; Delaporte E; Pauwels C; Franck N; Caux F; Picard C; Tancrede-Bohin E; Bernard P; Tron F; Hertl M; Musette P
N Engl J Med; 2007 Aug; 357(6):545-52. PubMed ID: 17687130
[TBL] [Abstract][Full Text] [Related]
30. Treatment of an infant with severe acute refractory immune thrombocytopenic purpura using combination therapy including rituximab.
Iesato K; Hatakeyama N; Yamamoto M; Hori T; Inazawa N; Tsutsumi H; Suzuki N
Pediatr Blood Cancer; 2009 Aug; 53(2):203-5. PubMed ID: 19301247
[TBL] [Abstract][Full Text] [Related]
31. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis.
Garcia-Chavez J; Majluf-Cruz A; Montiel-Cervantes L; Esparza MG; Vela-Ojeda J;
Ann Hematol; 2007 Dec; 86(12):871-7. PubMed ID: 17874322
[TBL] [Abstract][Full Text] [Related]
32. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy.
Andersen JC
N Engl J Med; 1994 Jun; 330(22):1560-4. PubMed ID: 8177245
[TBL] [Abstract][Full Text] [Related]
33. High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults.
Borst F; Keuning JJ; van Hulsteijn H; Sinnige H; Vreugdenhil G
Ann Hematol; 2004 Dec; 83(12):764-8. PubMed ID: 15309522
[TBL] [Abstract][Full Text] [Related]
34. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L
Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
[TBL] [Abstract][Full Text] [Related]
35. Effect of a single-cycle alternative dosing regimen for rituximab for recalcitrant pemphigus: a case series of 9 patients.
Matsukura S; Knowles SR; Walsh S; Shear NH
Arch Dermatol; 2012 Jun; 148(6):734-9. PubMed ID: 22351790
[TBL] [Abstract][Full Text] [Related]
36. Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia.
Barcellini W; Zaja F; Zaninoni A; Imperiali FG; Di Bona E; Fattizzo B; Consonni D; Cortelezzi A; Zanella A
Eur J Haematol; 2013 Dec; 91(6):546-51. PubMed ID: 24033754
[TBL] [Abstract][Full Text] [Related]
37. Eltrombopag, low-dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia.
Gómez-Almaguer D; Colunga-Pedraza PR; Gómez-De León A; Gutiérrez-Aguirre CH; Cantú-Rodríguez OG; Jaime-Pérez JC
Br J Haematol; 2019 Jan; 184(2):288-290. PubMed ID: 29270980
[No Abstract] [Full Text] [Related]
38. Low-dose rituximab is effective in pemphigus.
Horváth B; Huizinga J; Pas HH; Mulder AB; Jonkman MF
Br J Dermatol; 2012 Feb; 166(2):405-12. PubMed ID: 21967609
[TBL] [Abstract][Full Text] [Related]
39. Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results.
Medeot M; Zaja F; Vianelli N; Battista M; Baccarani M; Patriarca F; Soldano F; Isola M; De Luca S; Fanin R
Eur J Haematol; 2008 Sep; 81(3):165-9. PubMed ID: 18510702
[TBL] [Abstract][Full Text] [Related]
40. Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis.
Auger S; Duny Y; Rossi JF; Quittet P
Br J Haematol; 2012 Aug; 158(3):386-98. PubMed ID: 22612239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
